Aquestive Therapeutics, Inc. (AQST)
5.31
-0.07
(-1.30%)
USD |
NASDAQ |
Sep 03, 10:42
Aquestive Therapeutics Research and Development Expense (Annual) : 17.19M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 17.19M |
| December 31, 2024 | 20.28M |
| December 31, 2023 | 13.10M |
| December 31, 2022 | 17.31M |
| December 31, 2021 | 17.05M |
| Date | Value |
|---|---|
| December 31, 2020 | 19.89M |
| December 31, 2019 | 20.57M |
| December 31, 2018 | 23.11M |
| December 31, 2017 | 22.13M |
| December 31, 2016 | 15.45M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| LENZ Therapeutics, Inc. | 18.67M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Corcept Therapeutics, Inc. | 254.91M |
| Veru, Inc. | 15.59M |
| Johnson & Johnson | 14.83B |